Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage

被引:111
作者
García-Villarreal, L
Martínez-Lagares, F
Sierra, A
Guevara, C
Marrero, JM
Jiménez, E
Monescillo, A
Hernández-Cabrero, T
Alonso, JM
Fuentes, R
机构
[1] Univ Las Palmas Gran Canaria, Hosp Insular Univ, Serv Digest Disorders, Las Palmas Gran Canaria 35016, Las Palmas, Spain
[2] Univ Las Palmas Gran Canaria, Hosp Insular Univ, Vasc & Intervent Radiol Unit, Las Palmas Gran Canaria 35016, Las Palmas, Spain
[3] Univ Las Palmas Gran Canaria, Hosp Insular Univ, Serv Radiol, Las Palmas Gran Canaria 35016, Las Palmas, Spain
关键词
D O I
10.1002/hep.510290125
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Variceal hemorrhage continues to be a major cause of morbidity and mortality in cirrhotic patients. Transjugular intrahepatic portosystemic shunt (TIPS) is gaining wide acceptance as a treatment for several complications of portal hypertension. The aim of the current randomized study was to compare the transjugular shunt and endoscopic sclerotherapy (ES) for the prevention of variceal rebleeding (VB) in cirrhotic patients. Forty-six consecutive cirrhotic patients with variceal bleeding were randomly allocated to receive either transjugular shunt (22 patients) or ES (24 patients) 24 hours after control of bleeding. VB (50% vs. 9%) and early (first 6 weeks) VB (33% vs. 5%) were significantly more frequent in sclerotherapy patients; the actuarial probability of being free of VB was higher in the shunt group (P < .002). Eight patients (33%) of the sclerotherapy group and 3 patients (15%) of the shunt group died; the actuarial probability of survival was higher for the shunted patients (P <.05); 6 patients in the sclerotherapy group and none in the shunt group died from VB (P <.05). No difference was found in the proportion of patients with clinically evident hepatic encephalopathy (HE). These results show that the transjugular shunt is more effective than sclerotherapy in the prevention of both early and long-term VB. Moreover, a significant improvement in survival was found in the shunt group.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 19 条
[1]   CIRRHOTICS WITH VARICEAL HEMORRHAGE - THE IMPORTANCE OF THE TIME INTERVAL BETWEEN ADMISSION AND THE START OF ANALYSIS FOR SURVIVAL AND REBLEEDING RATES [J].
BURROUGHS, AK ;
MEZZANOTTE, G ;
PHILLIPS, A ;
MCCORMICK, PA ;
MCINTYRE, N .
HEPATOLOGY, 1989, 9 (06) :801-807
[2]   Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage [J].
Cabrera, J ;
Maynar, M ;
Granados, R ;
Gorriz, E ;
Reyes, R ;
PulidoDuque, JM ;
SanRoman, JLR ;
Guerra, C ;
Kravetz, D .
GASTROENTEROLOGY, 1996, 110 (03) :832-839
[3]   Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage - A randomized, controlled trial [J].
Cello, JP ;
Ring, EJ ;
Olcott, EW ;
Koch, J ;
Gordon, R ;
Sandhu, J ;
Morgan, DR ;
Ostroff, JW ;
Rockey, DC ;
Bacchetti, P ;
LaBerge, J ;
Lake, JR ;
Somberg, K ;
Doherty, C ;
Davila, M ;
McQuaid, K ;
Wall, SD .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (11) :858-+
[4]  
DAMICO G, 1995, HEPATOLOGY, V22, P332, DOI 10.1002/hep.1840220145
[5]   DEFINITIONS, METHODOLOGY AND THERAPEUTIC STRATEGIES IN PORTAL-HYPERTENSION - A CONSENSUS DEVELOPMENT WORKSHOP, BAVENO, LAKE MAGGIORE, ITALY, APRIL 5 AND 6, 1990 [J].
DEFRANCHIS, R ;
PASCAL, JP ;
ANCONA, E ;
BURROUGHS, AK ;
HENDERSON, M ;
FLEIG, W ;
GROSZMANN, R ;
BOSCH, J ;
SAUERBRUCH, T ;
SOEDERLUND, C ;
LEBREC, D ;
SOERENSEN, TIA ;
PAGLIARO ;
ALEXANDRINO, P ;
ARCIDIACONO, R ;
BATTAGLIA, G ;
BOLONDI, L ;
CALES, P ;
CESTARI, L ;
COSENTINO, F ;
CURZIO, M ;
DAMICO, G ;
GERTSCH, P ;
GERUNDA, G ;
KREJS, G ;
FACCIOLI, AM ;
MINOLI, G ;
MOELLER, S ;
NEVENS, F ;
POMIERLAYRARGUES, G ;
PRIMIGNANI, M ;
SABBA, C ;
SPINA, G ;
STARITZ, M ;
TINE, F ;
VANBUUREN, HR ;
WESTABY, D ;
ZIPARO, V .
JOURNAL OF HEPATOLOGY, 1992, 15 (1-2) :256-261
[6]   PORTAL PRESSURE, PRESENCE OF GASTROESOPHAGEAL VARICES AND VARICEAL BLEEDING [J].
GARCIATSAO, G ;
GROSZMANN, RJ ;
FISHER, RL ;
CONN, HO ;
ATTERBURY, CE ;
GLICKMAN, M .
HEPATOLOGY, 1985, 5 (03) :419-424
[7]  
GRAHAM DY, 1981, GASTROENTEROLOGY, V80, P800
[8]  
Jalan R, 1997, HEPATOLOGY, V26, P1115
[9]   CREATION OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNTS WITH THE WALLSTENT ENDOPROSTHESIS - RESULTS IN 100 PATIENTS [J].
LABERGE, JM ;
RING, EJ ;
GORDON, RL ;
LAKE, JR ;
DOHERTY, MM ;
SOMBERG, KA ;
ROBERTS, JP ;
ASCHER, NL .
RADIOLOGY, 1993, 187 (02) :413-420
[10]   Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: A randomized multicenter trial [J].
Merli, M ;
Salerno, F ;
Riggio, O ;
de Franchis, R ;
Fiaccadori, F ;
Meddi, P ;
Primignani, M ;
Pedretti, G ;
Maggi, A ;
Capocaccia, L ;
Lovaria, A ;
Ugolotti, U ;
Salvatori, F ;
Bezzi, M ;
Rossi, P .
HEPATOLOGY, 1998, 27 (01) :48-53